Familial benign copper deficiency, also known as cystic copper fibrosis or Wilson's disease, is a genetic disorder associated with impaired copper metabolism in the body. This condition causes copper to accumulate in tissues, which can lead to damage to the liver, brain and other organs. The key aspect is the fact that copper deficiency in this context does not mean a lack of this micronutrient, but, on the contrary, its excess, which accumulates due to a disruption in normal metabolism. The disease can have a variety of clinical manifestations, including symptoms related to the nervous system, liver and other organ systems, and requires a comprehensive approach to diagnosis and therapy.
History of the disease and interesting historical facts
Familial benign copper deficiency was first described in the early 20th century, when doctors began to notice unusual symptoms in patients, such as uncontrolled movements, problems with coordination, and changes in the liver. The first descriptions of a disease state associated with copper excess were made in 1912, when a link was established between clinical symptoms and a disorder in copper metabolism. Interestingly, over the past decades, many renowned scientists, including Coons and the elite of neuroscience, have studied this syndrome, leading to the formation of key theories explaining the mechanism of copper accumulation.
Epidemiology
Because familial benign copper deficiency is an inherited disorder, its prevalence varies by geographic and ethnic factors. Epidemiological studies estimate the incidence to be approximately 1 in 30,000 to 100,000 persons in populations with high health care coverage. The disorder is more common in certain ethnic groups, which may be related to genetic predisposition. The prevalence among men and women is low, and most cases are diagnosed in adolescence or young adulthood, but may also manifest in later life depending on the level of copper accumulation in the body.
Genetic predisposition to this disease
Familial benign copper deficiency is caused by mutations in the ATP7B gene, which is responsible for transporting copper in cells and removing it from the body. Absenteeism or defective functionality of this gene leads to accumulation of copper in the liver and other organs, which can cause a variety of clinical manifestations, including liver cirrhosis, neurological disorders, and psychiatric manifestations. Mutations in this gene are defined as recessive, meaning that two mutations, one from each parent, must be inherited for the disease to manifest. More than 500 different mutations have been identified in the ATP7B gene, and genetic testing can help diagnose the disease and determine its severity.
Risk factors for the development of this disease
There are several risk factors that contribute to the development of the disease, including:
- Heredity - the disease is inherited, and the presence of cases in the family significantly increases the risk.
- Habitat - Ecologists argue that areas with high concentrations of copper in the diet or environment can inhibit the normal functioning of copper metabolism.
- Digestive problems - having conditions that affect the absorption of nutrients can worsen the patient's condition.
Additionally, other potential risk factors include inadequate nutritional status and frequent stress, which may contribute to the worsening of clinical manifestations within an existing disease.
Diagnosis of this disease
A variety of methods are used to diagnose familial benign copper deficiency, including clinical, laboratory, and radiological studies. The main symptoms that a doctor will look for include:
- Neurological disorders - tremor, dyskinesia, mental changes.
- Liver problems - jaundice, liver enlargement, cirrhosis.
Laboratory tests include serum copper levels and urine copper tests. Radiological tests, such as ultrasound or MRI, can provide information about the liver and other organs. It is also important to conduct a differential diagnosis to rule out other diseases with similar symptoms, such as hepatitis and autoimmune disorders.
Treatment
Treatment of familial benign copper deficiency should be comprehensive and individualized for each patient. General treatment includes:
- Decreased copper levels in the body.
- Correction of disease symptoms.
Pharmacological treatment usually involves the administration of copper chelators, such as penicillamine, which help remove excess copper from the body. In some cases, surgery may be necessary, such as in the presence of cirrhosis of the liver or major complications associated with copper accumulation. It is also important to follow a diet that excludes foods rich in copper.
List of medications used to treat this disease
Among the main medications used in the treatment of familial benign copper deficiency are:
- Penicillamine is a copper chelator.
- Trientine is an alternative copper chelator.
- Zinc - reduces the absorption of copper in the intestine.
The dosage and duration of drug use depend on the severity of the disease and the clinical picture of each individual patient.
Disease monitoring
Monitoring patients with familial benign copper deficiency is essential to prevent complications. Regular monitoring may include:
- Periodic testing of copper levels in the blood and urine.
- Evaluation of liver and nervous system function using radiological methods.
The prognosis with timely treatment is favorable in most cases, but complications such as infectious diseases or chronic liver failure are possible, which may require more serious intervention.
Age-related features of the disease
Familial benign copper deficiency can manifest itself in different age groups with varying degrees of severity of symptoms. In children and adolescents, the disease often manifests itself with neurological symptoms, while in adults, liver dysfunction is predominantly observed. The importance of early diagnosis and treatment becomes especially relevant in childhood, when more serious consequences are possible.
Questions and Answers
- What are the main symptoms of copper deficiency?
The main symptoms include neurological disorders, jaundice, liver enlargement and mental changes. - How is the disease diagnosed?
Diagnosis includes laboratory tests for serum copper levels and urine analysis, as well as radiological examinations. - Who is mainly susceptible to this disease?
The disease is more common in patients with a family history, that is, those who have had cases of this disease in their family. - What is the treatment for this condition?
Treatment involves the use of copper chelators such as penicillamine and a special diet. - How often is it necessary to monitor the patient's condition?
Regular monitoring of blood copper levels and liver function is necessary at least every 3-6 months during active treatment.
Advice from Dr. Oleg Korzhikov
Dr. Oleg Korzhikov recommends that all patients with familial benign copper deficiency remember the importance of regular monitoring and timely correction of their condition. He noted that:
- It is important to monitor copper levels in your diet and avoid foods rich in this trace mineral, such as seafood and nuts.
- Regular visits to the doctor will allow you to promptly identify all changes and prevent possible complications.
- It is important to maintain a positive attitude, as the right approach to treatment and lifestyle can significantly improve the quality of life.
Familial benign copper deficiency requires a careful approach and comprehensive treatment, which can significantly improve the prognosis and quality of life of patients.
